Anesthesia: Page 34

NephRx licenses patent for oral mucositis treatment
By DrBicuspid.com staff writers
NephRx has gained rights to a U.S. patent related to the company's novel peptide NX002, which is being developed for the treatment of oral mucositis and diseases of the gastrointestinal tract.
November 29, 2011
Novartis loses appeal of ONJ lawsuit
By DrBicuspid.com staff writers
A federal judge has denied a bid by Novartis to overturn a 2010 verdict in which a jury decided Novartis failed to adequately warn consumers that using Zometa may cause osteonecrosis of the jaw (ONJ).
November 27, 2011
Surgical drug shortages put patients at risk
By DrBicuspid.com staff writers
The U.S. is facing ongoing shortages of several critical anesthesia medications, which could have potentially serious effects on patient care and safety, according to a special report in Anesthesia & Analgesia.
November 27, 2011
Oral analgesics & third-molar extractions: What works best?
By Rob Goszkowski
A study in the British Dental Journal comparing the efficacy of oral analgesics following third-molar extractions found that one drug combination in particular is most effective, although no single analgesic is effective in all patients, according to the authors.
November 27, 2011
2009 01 22 10 36 53 572 Older Woman 70
Milestone Scientific Q3 revenues dip slightly
By DrBicuspid.com staff writers
A "marketing shift" is being blamed for a decrease in Milestone Scientific's third-quarter revenues for 2011.
November 13, 2011
FDA OKs new drug for late-stage head/neck cancer
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Erbitux for use with chemotherapy to aid in the treatment of patients with late-stage head and neck cancer.
November 6, 2011
ADA updates guidelines for managing ONJ risk patients
By Rabia Mughal
A patient receiving antiresorptive therapy for the prevention and treatment of osteoporosis has a low risk of developing osteonecrosis of the jaw (ONJ), and benefits of the medication outweigh the risk of ONJ, according to an advisory statement from the ADA.
November 3, 2011
2009 01 22 10 36 53 572 Older Woman 70
Vigilance key to sedation safety with at-risk patients
By Rob Goszkowski
In the latest issue of Anesthesia Progress, two dentists outline how to recognize and manage cardiovascular complications that can arise during sedation, particularly with medically compromised patients.
October 30, 2011
2009 08 04 11 11 40 313 Risk 70
Fla. 5-year-old's sedation death ruled an accident
By DrBicuspid.com staff writers
The 2010 death of a 5-year-old Florida boy who was sedated prior to having dental work done has been ruled an accident.
October 27, 2011
$1M settlement in Ohio girl's sedation death
By DrBicuspid.com staff writers
The parents of a 13-year-old Ohio girl who died in January after receiving intravenous sedation for oral surgery will receive nearly $700,000 from the insurance company representing Henry Mazorow, DDS.
October 27, 2011
Partnership enables e-prescribing of schedule II-V drugs
By DrBicuspid.com staff writers
DrFirst has partnered with dental software company DentiMax to use electronic health records to e-prescribe controlled substances.
October 4, 2011
Merck wins 5th Fosamax/ONJ trial
By DrBicuspid.com staff writers
A federal court in New York has found in favor of Merck in the Secrest v. Merck case, rejecting the claims of a Florida woman who said she developed osteonecrosis of the jaw (ONJ) and related dental problems after using Fosamax, a bisphosphonate commonly used to treat osteoporosis.
October 2, 2011
Previous Page
Page 34 of 56
Next Page